Firm Selling Notes to Raise Capital for AIDS Drug
Newport Pharmaceuticals International, a Newport Beach drug maker, said it has begun selling $12 million in convertible notes to raise money to pay for further research of Isoprinosine, the medication it hopes can be used by patients with immune deficiency syndrome and AIDS-related ailments.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
